ebselen has been researched along with Body Weight in 8 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We sought to investigate whether long-term administration of seleno-glutathione peroxidase mimic ebselen (PZ51) would have a protective effect on cortical neurons in SHRsp, and, if so, the possible mechanisms of this effect." | 5.33 | Protective effect of antioxidant ebselen (PZ51) on the cerebral cortex of stroke-prone spontaneously hypertensive rats. ( Liu, LS; Sui, H; Wang, PH; Wang, W, 2005) |
| "Pretreatment with ebselen, which induced significant (P < 0." | 5.32 | Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. ( Alborch, E; Burguete, MC; Marín, N; Pérez-Asensio, FJ; Pitarch, C; Romero, FJ; Salom, JB; Torregrosa, G, 2004) |
| "To investigate whether extrinsic antioxidant seleno-glutathione peroxidase mimic ebselen (PZ51) can protect endothelium and vascular structure of stroke-prone spontaneously hypertensive rats (SHRsp) during the chronic process of hypertension." | 3.73 | Effect of glutathione peroxidase mimic ebselen (PZ51) on endothelium and vascular structure of stroke-prone spontaneously hypertensive rats. ( Liu, LS; Sui, H; Wang, PH; Wang, W, 2005) |
| " We sought to investigate whether long-term administration of seleno-glutathione peroxidase mimic ebselen (PZ51) would have a protective effect on cortical neurons in SHRsp, and, if so, the possible mechanisms of this effect." | 1.33 | Protective effect of antioxidant ebselen (PZ51) on the cerebral cortex of stroke-prone spontaneously hypertensive rats. ( Liu, LS; Sui, H; Wang, PH; Wang, W, 2005) |
| "Pretreatment with ebselen, which induced significant (P < 0." | 1.32 | Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. ( Alborch, E; Burguete, MC; Marín, N; Pérez-Asensio, FJ; Pitarch, C; Romero, FJ; Salom, JB; Torregrosa, G, 2004) |
| " Therefore, the long-term administration of ebselen might be expected to induce an immunocompromised state in the host." | 1.29 | Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen. ( Arai, M; Kuruto, R; Masayasu, H; Motohashi, T; Nozawa, R, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Yerbury, JJ | 1 |
| Cashman, NR | 1 |
| Mahadevan, J | 1 |
| Parazzoli, S | 1 |
| Oseid, E | 1 |
| Hertzel, AV | 1 |
| Bernlohr, DA | 1 |
| Vallerie, SN | 1 |
| Liu, CQ | 1 |
| Lopez, M | 1 |
| Harmon, JS | 1 |
| Robertson, RP | 1 |
| Salom, JB | 1 |
| Pérez-Asensio, FJ | 1 |
| Burguete, MC | 1 |
| Marín, N | 1 |
| Pitarch, C | 1 |
| Torregrosa, G | 1 |
| Romero, FJ | 1 |
| Alborch, E | 1 |
| Sui, H | 2 |
| Wang, W | 2 |
| Wang, PH | 2 |
| Liu, LS | 2 |
| Nozawa, R | 1 |
| Arai, M | 1 |
| Kuruto, R | 1 |
| Motohashi, T | 1 |
| Masayasu, H | 1 |
| Kono, H | 1 |
| Arteel, GE | 1 |
| Rusyn, I | 1 |
| Sies, H | 1 |
| Thurman, RG | 1 |
| Pritsos, CA | 1 |
| Sokoloff, M | 1 |
| Gustafson, DL | 1 |
8 other studies available for ebselen and Body Weight
| Article | Year |
|---|---|
Selenium-based compounds: Emerging players in the ever-unfolding story of SOD1 in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Azoles; Body Weight; Disease Models, Animal; Humans; Isoindo | 2020 |
Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves β-cell mass and function in ZDF rats.
Topics: Adipocytes; Animals; Antioxidants; Apoptosis; Azoles; Blood Glucose; Body Weight; Cell Differentiati | 2013 |
Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia.
Topics: Administration, Oral; Animals; Azoles; Body Weight; Brain; Brain Chemistry; Brain Ischemia; Drug Adm | 2004 |
Protective effect of antioxidant ebselen (PZ51) on the cerebral cortex of stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Azoles; Blood Pressure; Blotting, Western; Body Weight; Cerebral Cortex; Hype | 2005 |
Effect of glutathione peroxidase mimic ebselen (PZ51) on endothelium and vascular structure of stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Azoles; Blood Pressure; Blotting, Western; Body Weight; Carotid Arteries; End | 2005 |
Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoles; Body Weight; Calcitriol; Candidiasis; Carc | 1996 |
Ebselen prevents early alcohol-induced liver injury in rats.
Topics: Alanine Transaminase; Aldehydes; Animals; Antioxidants; Azoles; Body Weight; Enteral Nutrition; Etha | 2001 |
PZ-51 (Ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity.
Topics: Acetylcysteine; Animals; Antioxidants; Azoles; Body Weight; Chemical and Drug Induced Liver Injury; | 1992 |